<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(1)</volume><submitter>Tadege M</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>The purpose of this study was to identify the major risk factors, which contributed to shortened survival time to death of HIV patients on antiretroviral therapy. Six-hundred HIV patients were included from two hospitals and six health centers record from January 2003 to December 2017. Kaplan-Meier and Cox proportional hazard model were implemented.&lt;h4>Results&lt;/h4>From the Kaplan-Meier, log-rank test result indicated that there was a significant difference between tuberculosis comorbidity (P = .000), occupation (P = .027), and WHO clinical stage (P = .012) on the survival experience of patients at 5% statistical significance level. From the Cox regression result, the risk of death for patients who lived with tuberculosis was about 2.872-fold times higher than those patients who were negative. Most of the HIV/AIDS patients on antiretroviral therapy were died in a short period due to tuberculosis comorbidity, began with lower amount of CD4, being underweight, merchant, and being on WHO clinical stage IV.</pubmed_abstract><journal>BMC research notes</journal><pagination>761</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6202867</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Time to death predictors of HIV/AIDS infected patients on antiretroviral therapy in Ethiopia.</pubmed_title><pmcid>PMC6202867</pmcid><pubmed_authors>Tadege M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Time to death predictors of HIV/AIDS infected patients on antiretroviral therapy in Ethiopia.</name><description>&lt;h4>Objective&lt;/h4>The purpose of this study was to identify the major risk factors, which contributed to shortened survival time to death of HIV patients on antiretroviral therapy. Six-hundred HIV patients were included from two hospitals and six health centers record from January 2003 to December 2017. Kaplan-Meier and Cox proportional hazard model were implemented.&lt;h4>Results&lt;/h4>From the Kaplan-Meier, log-rank test result indicated that there was a significant difference between tuberculosis comorbidity (P = .000), occupation (P = .027), and WHO clinical stage (P = .012) on the survival experience of patients at 5% statistical significance level. From the Cox regression result, the risk of death for patients who lived with tuberculosis was about 2.872-fold times higher than those patients who were negative. Most of the HIV/AIDS patients on antiretroviral therapy were died in a short period due to tuberculosis comorbidity, began with lower amount of CD4, being underweight, merchant, and being on WHO clinical stage IV.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Oct</publication><modification>2025-04-20T00:09:17.715Z</modification><creation>2019-03-27T00:05:27Z</creation></dates><accession>S-EPMC6202867</accession><cross_references><pubmed>30359289</pubmed><doi>10.1186/s13104-018-3863-y</doi></cross_references></HashMap>